Vor Biopharma Inc. (VOR)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $4k
- Jul 16 · No plan
- Form 4 sales
- 28
- On record
- Form 144 notices
- 22
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- Jul 16, 2026No plan
Shah Rajeev M., 10% owner, sold under 0.1% of their holdings
$4k213 shares at $19.75
- Apr 22, 2026No plan
Shah Rajeev M., Director, 10% owner, sold 6.4% of their holdings
$2.6M165,150 shares at $15.77
- Apr 20, 2026No plan
Ra Capital Management, L.P., Director, 10% owner, sold 19.7% of their holdings
$10.2M630,374 shares at $16.14
- Apr 15, 2026No plan
Ra Capital Management, L.P., Director, 10% owner, sold 18.8% of their holdings
$11.9M737,989 shares at $16.10
- Apr 10, 2026No plan
Shah Rajeev M., Director, 10% owner, sold 13.6% of their holdings
$10.2M620,133 shares at $16.50
- Apr 6, 2026No plan
Kolchinsky Peter, Director, 10% owner, sold 15.7% of their holdings
$14.5M849,257 shares at $17.10
- Oct 30, 2025Unusual
Kolchinsky Peter, Director, 10% owner, sold 33.9% of their holdings
$10.4M400,408 shares at $25.90
- Oct 27, 2025No plan
Ra Capital Management, L.P., Director, 10% owner, sold 15.8% of their holdings
$6.2M221,166 shares at $28.06
- Oct 21, 2025No plan
RA Capital Nexus Fund, L.P., Director, sold 7.7% of their holdings
$3.4M117,050 shares at $29.34
- Oct 21, 2025No plan
Reprogrammed Interchange LLC, 10% owner, sold 3.1% of their holdings
$1.1M37,533 shares at $30.19
Every transaction
Loading transactions…
Sales, notices and lockups (50)
Export watchlist as CSV| Source | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 16, 2026 | Jul 21, 2026 | Shah Rajeev M. | VOR | 10% owner | Form 4 sale | 213 | $4k | 0.0% | No plan | SEC |
| Apr 22, 2026 | Apr 24, 2026 | Shah Rajeev M. | VOR | Director, 10% owner | Form 4 sale | 165,150 | $2.6M | 6.4% | No plan | SEC |
| Apr 20, 2026 | Apr 21, 2026 | Ra Capital Management, L.P. | VOR | Director, 10% owner | Form 4 sale | 630,374 | $10.2M | 19.7% | No plan | SEC |
| Apr 15, 2026 | Apr 15, 2026 | Ra Capital Management, L.P. | VOR | Director, 10% owner | Form 4 sale | 737,989 | $11.9M | 18.8% | No plan | SEC |
| Apr 10, 2026 | Apr 10, 2026 | Shah Rajeev M. | VOR | Director, 10% owner | Form 4 sale | 620,133 | $10.2M | 13.6% | No plan | SEC |
| Apr 6, 2026 | Apr 6, 2026 | Kolchinsky Peter | VOR | Director, 10% owner | Form 4 sale | 849,257 | $14.5M | 15.7% | No plan | SEC |
| Oct 30, 2025 | Oct 30, 2025 | Kolchinsky Peter | VOR | Director, 10% owner | Form 4 sale | 400,408 | $10.4M | 33.9% | Unusual | SEC |
| Oct 27, 2025 | Oct 27, 2025 | Ra Capital Management, L.P. | VOR | Director, 10% owner | Form 4 sale | 221,166 | $6.2M | 15.8% | No plan | SEC |
| Oct 21, 2025 | Oct 22, 2025 | RA Capital Nexus Fund, L.P. | VOR | Director | Form 4 sale | 117,050 | $3.4M | 7.7% | No plan | SEC |
| Oct 21, 2025 | Oct 21, 2025 | Reprogrammed Interchange LLC | VOR | 10% owner | Form 4 sale | 37,533 | $1.1M | 3.1% | No plan | SEC |
| Oct 20, 2025 | Oct 20, 2025 | RA Capital Nexus Fund, L.P. | VOR | Director, 10% Stockholder | Form 144 notice | 15,104 | $445k | Notice | SEC | |
| Oct 20, 2025 | Oct 20, 2025 | RA Capital Healthcare Fund LP | VOR | Director, 10% Stockholder | Form 144 notice | 76,919 | $2.3M | Notice | SEC | |
| Oct 17, 2025 | Oct 17, 2025 | RA Capital Nexus Fund, L.P. | VOR | Director, 10% Stockholder | Form 144 notice | 42,816 | $1.2M | Notice | SEC | |
| Oct 17, 2025 | Oct 17, 2025 | RA Capital Healthcare Fund LP | VOR | Director, 10% Stockholder | Form 144 notice | 218,043 | $6.3M | Notice | SEC | |
| Oct 17, 2025 | Oct 17, 2025 | Shah Rajeev M. | VOR | Director, 10% owner | Form 4 sale | 464,025 | $13.7M | 96.8% | Unusual | SEC |
| Oct 16, 2025 | Oct 17, 2025 | Reprogrammed Interchange LLC | VOR | 10% owner | Form 4 sale | 73,676 | $2.3M | 5.8% | No plan | SEC |
| Oct 16, 2025 | Oct 16, 2025 | RA Capital Nexus Fund, L.P. | VOR | Director, 10% Stockholder | Form 144 notice | 24,916 | $724k | Notice | SEC | |
| Oct 16, 2025 | Oct 16, 2025 | RA Capital Healthcare Fund LP | VOR | Director, 10% Stockholder | Form 144 notice | 126,887 | $3.7M | Notice | SEC | |
| Oct 15, 2025 | Oct 15, 2025 | RA Capital Nexus Fund, L.P. | VOR | Director, 10% Stockholder | Form 144 notice | 8,430 | $255k | Notice | SEC | |
| Oct 15, 2025 | Oct 15, 2025 | RA Capital Healthcare Fund LP | VOR | Director, 10% Stockholder | Form 144 notice | 42,933 | $1.3M | Notice | SEC | |
| Oct 14, 2025 | Oct 15, 2025 | Reprogrammed Interchange LLC | VOR | 10% owner | Form 4 sale | 96,657 | $3M | 7.0% | No plan | SEC |
| Oct 9, 2025 | Oct 10, 2025 | Reprogrammed Interchange LLC | VOR | 10% owner | Form 4 sale | 124,146 | $4.1M | 8.3% | No plan | SEC |
| Oct 7, 2025 | Oct 8, 2025 | Reprogrammed Interchange LLC | VOR | 10% owner | Form 4 sale | 98,387 | $3.6M | 6.2% | No plan | SEC |
| Oct 3, 2025 | Oct 3, 2025 | Reprogrammed Interchange LLC | VOR | 10% owner | Form 4 sale | 41,752 | $1.6M | 2.5% | No plan | SEC |
| Sep 16, 2025 | Sep 18, 2025 | Hoffman Reid | VOR | 10% owner | Form 4 sale | 447,278 | $689k | 1.3% | No plan | SEC |
| Sep 15, 2025 | Sep 15, 2025 | Hoffman Reid | VOR | 10% owner | Form 4 sale | 984,805 | $1.7M | 2.9% | No plan | SEC |
| Sep 10, 2025 | Sep 10, 2025 | Hoffman Reid | VOR | 10% owner | Form 4 sale | 1.3M | $2.5M | 3.6% | No plan | SEC |
| Sep 5, 2025 | Sep 5, 2025 | Hoffman Reid | VOR | 10% owner | Form 4 sale | 1.4M | $2.8M | 3.8% | No plan | SEC |
| Sep 2, 2025 | Sep 3, 2025 | Reprogrammed Interchange LLC | VOR | 10% Stockholder | Form 144 notice | 23M | $46.1M | Notice | SEC | |
| Aug 28, 2025 | Aug 29, 2025 | Hoffman Reid | VOR | 10% owner | Form 4 sale | 1.4M | $2.9M | 3.7% | No plan | SEC |
| Aug 26, 2025 | Aug 27, 2025 | Hoffman Reid | VOR | 10% owner | Form 4 sale | 671,536 | $1.4M | 1.7% | No plan | SEC |
| Aug 11, 2025 | Aug 11, 2025 | Ang Robert | VOR | Officer, Director | Form 144 notice | 18,382 | $36k | Notice | SEC | |
| Aug 4, 2025 | Aug 4, 2025 | Lundberg Sven Ante | VOR | Director | Form 144 notice | 29,432 | $62k | Notice | SEC | |
| Jul 16, 2025 | Jul 16, 2025 | Ang Robert | VOR | Officer, Director | Form 144 notice | 197,937 | $415k | Notice | SEC | |
| Jul 15, 2025 | Jul 15, 2025 | Ang Robert | VOR | Officer, Director | Form 144 notice | 214,135 | $521k | Notice | SEC | |
| Jul 10, 2025 | Jul 10, 2025 | Ang Robert | VOR | Officer, Director | Form 144 notice | 596,885 | $1.4M | Notice | SEC | |
| Jul 2, 2025 | Jul 2, 2025 | Ang Robert | VOR | Officer, Director | Form 144 notice | 44,936 | $80k | Notice | SEC | |
| Jul 1, 2025 | Jul 1, 2025 | Ang Robert | VOR | Officer, Director | Form 144 notice | 40,468 | $70k | Notice | SEC | |
| Jun 30, 2025 | Jun 30, 2025 | Ang Robert | VOR | Officer, Director | Form 144 notice | 40,627 | $70k | Notice | SEC | |
| Feb 13, 2025 | Feb 18, 2025 | Attar Eyal C. | VOR | CHIEF MEDICAL OFFICER | Form 4 sale | 2,227 | $3k | 1.7% | Routine | SEC |
| Feb 13, 2025 | Feb 13, 2025 | Attar Eyal C. | VOR | Officer | Form 144 notice | 2,227 | $3k | Notice | SEC | |
| Feb 10, 2025 | Feb 12, 2025 | Attar Eyal C. | VOR | CHIEF MEDICAL OFFICER | Form 4 sale | 2,554 | $3k | 1.9% | Routine | SEC |
| Feb 10, 2025 | Feb 10, 2025 | Attar Eyal C. | VOR | Officer | Form 144 notice | 2,554 | $4k | Notice | SEC | |
| Dec 27, 2024 | Dec 31, 2024 | Attar Eyal C. | VOR | CHIEF MEDICAL OFFICER | Form 4 sale | 10,334 | $13k | 11.3% | Routine | SEC |
| Dec 27, 2024 | Dec 27, 2024 | Attar Eyal C. | VOR | Officer | Form 144 notice | 10,334 | $9k | Notice | SEC | |
| Jul 19, 2024 | Jul 19, 2024 | Jorgensen Nathan D. | VOR | Officer | Form 144 notice | 29,269 | $27k | Notice | SEC | |
| Jun 3, 2024 | Jun 4, 2024 | Attar Eyal C. | VOR | CHIEF MEDICAL OFFICER | Form 4 sale | 14,645 | $20k | 13.2% | Routine | SEC |
| Jun 3, 2024 | Jun 3, 2024 | Attar Eyal C. | VOR | Officer | Form 144 notice | 14,645 | $20k | Notice | SEC | |
| Nov 16, 2021 | Nov 18, 2021 | Schwab Andrew J. | VOR | 10% owner | Form 4 sale | 330,706 | $5.1M | 15.8% | Plan not stated | SEC |
| Nov 16, 2021 | Nov 18, 2021 | Parmar Kush | VOR | Director, 10% owner | Form 4 sale | 330,706 | $5.1M | 15.8% | Plan not stated | SEC |